March 13: Repurposing Older Drugs Could Raise New Hope for Breast Cancer Treatment

Medicines for diabetes, blood disorders show promise for triple negative cancers

An estimated 15 to 20 percent of all breast cancer patients are “triple negative,” meaning women lack three crucial treatment targets—the estrogen receptor, the progesterone receptor and human epidermal growth factor receptor 2. Because they lack these targets, most triple negative patients are treated with standard chemotherapy, rather than the preferred targeted drugs.

Read the full article here on the University of Chicago News.